Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pancreatic Neoplasms × MK 2206 × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Gallbladder Neoplasms 2 Colonic Neoplasms 2 Waldenstrom Macroglobulinemia 1 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Salivary Gland Neoplasms 1 Recurrent Squamous Cell Carcinoma of the Nasopharynx 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

Gemcitabine 294 Fluorouracil 81 Oxaliplatin 80 130-nm albumin-bound paclitaxel 67 Capecitabine 60 Leucovorin 55 Albumin-Bound Paclitaxel 53 Radiotherapy 51 Irinotecan 44 Taxes 38 Cisplatin 36 Erlotinib Hydrochloride 34 Radiosurgery 32 pembrolizumab 29 Docetaxel 27 S 1 (combination) 26 Bevacizumab 23 folfirinox 22 Nivolumab 21 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 17 Cetuximab 17 Radiation 16 irinotecan sucrosofate 15 Drug Therapy 15 Surgical Procedures, Operative 14 Specimen Handling 11 Paclitaxel 11 Biopsy 11 durvalumab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01658943 2016-03-09

S1115

National Cancer Institute (NCI)

Phase 2 Completed

137 enrolled 12 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡